| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |